Corvus Pharmaceuticals (CRVS) Operating Income (2015 - 2026)
Corvus Pharmaceuticals (CRVS) posted Operating Income of -$19.3 million for Q2 2026, compared with -$10.26 million a year earlier.
Powered by 
Analysis
Corvus Pharmaceuticals (CRVS) Operating Income (2015 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Operating Income at Corvus Pharmaceuticals was -$55.01 million; for FY2023, it was -$23.41 million.
- In prior years, Corvus Pharmaceuticals' Operating Income was -$32.57 million in FY2022, -$38.63 million in FY2021, -$43.76 million in FY2020 and -$48.85 million in FY2019.
- The Q2 2026 figure stands as the lowest quarterly Operating Income in data going back to Q1 2015.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 11.75 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 7.14 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 6.43 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | -584.00 Mn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 4.75 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 3.16 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 3.51 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | -10.39 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 4.27 Bn |
| 10 | Corvus Pharmaceuticals | 919.44 Mn | 407.88 Mn | - | -19.30 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -19.30 Mn |
| Mar 31, 2026 | -14.88 Mn |
| Sep 30, 2025 | -10.57 Mn |
| Jun 30, 2025 | -10.26 Mn |
| Mar 31, 2025 | -9.92 Mn |
| Sep 30, 2024 | -7.26 Mn |
| Jun 30, 2024 | -5.94 Mn |
| Mar 31, 2024 | -6.25 Mn |
| Dec 31, 2023 | -5.65 Mn |
| Sep 30, 2023 | -5.56 Mn |
| Jun 30, 2023 | -5.62 Mn |
| Mar 31, 2023 | -6.57 Mn |
| Dec 31, 2022 | -5.67 Mn |
| Sep 30, 2022 | -12.47 Mn |
| Jun 30, 2022 | -7.01 Mn |
| Mar 31, 2022 | -7.41 Mn |
| Dec 31, 2021 | -6.81 Mn |
| Sep 30, 2021 | -9.05 Mn |
| Jun 30, 2021 | -11.29 Mn |
| Mar 31, 2021 | -11.48 Mn |
API Access
Corvus Pharmaceuticals Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-income&ticker=CRVS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-income", "ticker": "CRVS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-income&ticker=CRVS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();